BREAKING

Precision BioSciences (DTIL) Swings to $1.05 EPS in Q4, Reversing $2.22 Year-Ago Loss 50 seconds ago CareCloud (CCLD) Reports EPS of $0.04 for Q4 FY25; Revenue Rises 22% 18 minutes ago Alliance Laundry (ALH) Q4 EPS Beats at $0.24; Guides FY26 Revenue 33 minutes ago Saga Communications (SGA) Reports Adjusted EPS of $1.27; Revenue Declines to $26.5M 47 minutes ago Gambling.com (GAMB) Posts $0.30 Adjusted EPS on Record $46.2M Revenue, Up 31% YoY 1 hour ago Li Auto (LI) Earnings Beat by 15.2% Despite Revenue Plunging 90.7% Year-Over-Year 1 hour ago Full Truck Alliance (YMM) Q4 Revenue Plummets 85.6% to $456.5M as EPS Falls 85.9% to $0.14 1 hour ago Highpeak Energy Inc (HPK) Reports Wider Loss Q4 EPS Estimates by 188.1% 2 hours ago Gyre Therapeutics (GYRE) Posts Q4 FY25 Loss of $0.02; misses estimates 2 hours ago Sleep Number (SNBR) Q4 Loss Widens to $2.55/Share as Revenue Falls 7.8% to $347.4M 2 hours ago Precision BioSciences (DTIL) Swings to $1.05 EPS in Q4, Reversing $2.22 Year-Ago Loss 50 seconds ago CareCloud (CCLD) Reports EPS of $0.04 for Q4 FY25; Revenue Rises 22% 18 minutes ago Alliance Laundry (ALH) Q4 EPS Beats at $0.24; Guides FY26 Revenue 33 minutes ago Saga Communications (SGA) Reports Adjusted EPS of $1.27; Revenue Declines to $26.5M 47 minutes ago Gambling.com (GAMB) Posts $0.30 Adjusted EPS on Record $46.2M Revenue, Up 31% YoY 1 hour ago Li Auto (LI) Earnings Beat by 15.2% Despite Revenue Plunging 90.7% Year-Over-Year 1 hour ago Full Truck Alliance (YMM) Q4 Revenue Plummets 85.6% to $456.5M as EPS Falls 85.9% to $0.14 1 hour ago Highpeak Energy Inc (HPK) Reports Wider Loss Q4 EPS Estimates by 188.1% 2 hours ago Gyre Therapeutics (GYRE) Posts Q4 FY25 Loss of $0.02; misses estimates 2 hours ago Sleep Number (SNBR) Q4 Loss Widens to $2.55/Share as Revenue Falls 7.8% to $347.4M 2 hours ago

ADVERTISEMENT

Breaking News

Harvard Bioscience (HBIO) Reports Q4 Loss of $0.06/Share, Revenue Falls 3.3% to $23.7M

Harvard Bioscience reports Q4 loss of $0.06/share on revenue of $23.7M, down 3.3% year-over-year, with Q1 guidance suggesting continued pressure.

March 12, 2026 2 min read

Harvard Bioscience reports Q4 loss of $0.06/share on revenue of $23.7M, down 3.3% year-over-year, with Q1 guidance suggesting continued pressure.

Earnings Per Share (GAAP)

$-0.06

estimate N/A

Revenue

$23.7M

estimate N/A

What to Watch: The Q1 2026 guidance midpoint of $23.5 million implies continued revenue pressure. Watch whether management can stabilize the top line and return to profitability when the company reports Q1 results in May 2026.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

ADVERTISEMENT

Tags: #HBIO